These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
154 related items for PubMed ID: 2111923
1. Killing intracellular mycobacteria in in vitro macrophage systems: what may be the role of known host microbicidal mechanisms? Rastogi N. Res Microbiol; 1990 Feb; 141(2):217-30. PubMed ID: 2111923 [No Abstract] [Full Text] [Related]
2. Intracellular killing of mycobacteria. Crowle AJ. Res Microbiol; 1990 Feb; 141(2):231-6. PubMed ID: 2111924 [No Abstract] [Full Text] [Related]
3. Slowly growing mycobacteria and chronic skin disorders. Mattila JO, Katila ML, Vornanen M. Clin Infect Dis; 1996 Nov; 23(5):1043-8. PubMed ID: 8922800 [Abstract] [Full Text] [Related]
4. [Attempts to elucidate reasons why mycobacterial infections are intractable, by using an experimental mouse infection model]. Tomioka H. Nihon Hansenbyo Gakkai Zasshi; 1996 Nov; 65(3):155-65. PubMed ID: 9050354 [Abstract] [Full Text] [Related]
5. Killing by antimycobacterial agents of AIDS-derived strains of Mycobacterium avium complex inside cells of the mouse macrophage cell line J774. Yajko DM, Nassos PS, Sanders CA, Hadley WK. Am Rev Respir Dis; 1989 Nov; 140(5):1198-203. PubMed ID: 2817581 [Abstract] [Full Text] [Related]
6. The role of macrophages in host defence mechanisms against Mycobacterium avium complex infection induced in mice. Saito H, Tomioka H. Res Microbiol; 1990 Feb; 141(2):206-12. PubMed ID: 2345799 [No Abstract] [Full Text] [Related]
12. Immunity to mycobacteria. Orme IM. Curr Opin Immunol; 1993 Aug; 5(4):497-502. PubMed ID: 8216924 [Abstract] [Full Text] [Related]
13. Sources of variability in assays of the interaction of mycobacteria with mononuclear phagocytes: of mice and men. Ellner JJ. Res Microbiol; 1990 Feb; 141(2):237-40. PubMed ID: 2111925 [No Abstract] [Full Text] [Related]
15. Interferon gamma fails to activate human monocyte-derived macrophages to kill or inhibit the replication of a non-pathogenic mycobacterial species. Robertson AK, Andrew PW. Microb Pathog; 1991 Oct; 11(4):283-8. PubMed ID: 1813779 [Abstract] [Full Text] [Related]
17. Growth within macrophages increases the efficiency of Mycobacterium avium in invading other macrophages by a complement receptor-independent pathway. Bermudez LE, Parker A, Goodman JR. Infect Immun; 1997 May; 65(5):1916-25. PubMed ID: 9125580 [Abstract] [Full Text] [Related]
18. Combined effects of ATP on the therapeutic efficacy of antimicrobial drug regimens against Mycobacterium avium complex infection in mice and roles of cytosolic phospholipase A2-dependent mechanisms in the ATP-mediated potentiation of antimycobacterial host resistance. Tomioka H, Sano C, Sato K, Ogasawara K, Akaki T, Sano K, Cai SS, Shimizu T. J Immunol; 2005 Nov 15; 175(10):6741-9. PubMed ID: 16272330 [Abstract] [Full Text] [Related]
20. Late acquisition of hyporesponsiveness to lipopolysaccharide by Mycobacterium avium-infected human macrophages in producing tumor necrosis factor-alpha but not interleukin-1 beta and -6. Fattorini L, Xiao Y, Ausiello CM, Urbani F, laSala A, Mattei M, Orefici G. J Infect Dis; 1996 Apr 15; 173(4):1030-4. PubMed ID: 8603946 [Abstract] [Full Text] [Related] Page: [Next] [New Search]